Bioventus stock is upgraded to a "Buy" amid a breakout driven by favorable regulatory developments. Here's what investors ...

Our latest reader photo challenge focuses on water. Learn how to capture movement and reflections.

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

A few weeks ahead of training camp, we have time to revisit the biggest moves of the offseason. With a closer look at major ...

Arguing about the NASCAR's most iconic drivers of all time is basically a second religion in the infield. The only thing ...

MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland ...

Patrick Sandoval’s rehab assignment has expired and the Red Sox need to make a decision. On Saturday, he fired five shutout innings for the Portland Sea Dogs. With no options remaining, the team needs ...

Skyroot is preparing for Vikram 1, a mission that will make it the first private Indian company to launch a commercial ...

Manoj Menon, Head of Research & Consumer Analyst at ICICI Securities, flagged Colgate as a longstanding underweight call, ...

At Polygon, we collectively agreed that Blue Prince was the best game of 2025. The puzzle-roguelike from Dogubomb, led by ...

The Minnesota Vikings arguably have a handful of contenders for “most promising player” in 2026, including any rookie drafted ...

Everything that happens in the NFL has additional context when viewed from a fantasy football perspective. From position ...